查看購物車
  • Simplified Chinese
  • English
  • Japanese
植入式胰島素幫浦市場規模、佔有率、成長分析（按幫浦類型、儲液器容量、輸注方式、最終用戶、年齡層、適應症、通路和地區分類）－2025-2032年產業預測
市場調查報告書
商品編碼
1859409

植入式胰島素幫浦市場規模、佔有率、成長分析（按幫浦類型、儲液器容量、輸注方式、最終用戶、年齡層、適應症、通路和地區分類）－2025-2032年產業預測

Implantable Insulin Pump Market Size, Share, and Growth Analysis, By Pump Type, By Reservoir Size, By Delivery Mode, By End User, By Age Group, By Indication, By Distribution Channel, By Region - Industry Forecast 2025-2032
出版日期: | 出版商: SkyQuest | 英文 188 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023 年全球植入式胰島素幫浦市場價值為 322 億美元，預計從 2024 年的 393.5 億美元成長到 2032 年的 1956.6 億美元，在預測期（2025-2032 年）內複合年成長率為 22.2%。

全球植入式胰島素幫浦市場正經歷強勁成長，這主要得益於糖尿病盛行率的不斷上升，推動了對先進胰島素輸注系統的需求。患者越來越傾向於持續、精準的胰島素輸注，因為他們希望更好地控制血糖，減少長期併發症。技術進步改進了胰島素幫浦的設計，使其更加可靠、易於使用。人們對有效糖尿病管理的認知不斷提高，加上醫療政策和報銷計畫的支持，進一步推動了胰島素幫浦的普及。然而，高昂的成本、手術費用、在發展中地區認可度有限、嚴格的監管障礙、潛在的感染風險以及持續的設備維護需求等挑戰，可能會阻礙市場擴張。總而言之，植入式胰島素幫浦的發展既面臨機遇，也面臨挑戰。

全球植入式胰島素幫浦市場按幫浦類型、儲液器容量、輸注方式、最終用戶、年齡層、適應症、通路和地區進行細分。按泵類型分類，市場分為可編程植入式泵、閉合迴路泵、開放回路型泵、不可編程植入式泵和其他類型。依儲液器容量分類，市場分為小容量（<10 mL）、中容量（10-20 mL）、大容量（>20 mL）及其他類型。依輸注方式分類，市場分為持續基礎大劑量投藥、餐前胰島素輸注、基礎-餐前聯合輸注及其他類型。按最終用戶分類，市場分為醫院、門診手術中心 (ASC)、糖尿病專科診所、居家醫療機構和其他機構。依年齡層別分類，市場分為兒童（<17歲）、成人（18-64歲）及老年人（>65歲）。依適應症分類，市場可分為第1型糖尿病（T1DM）、第2型糖尿病（T2DM）及其他類型。依分銷管道分類，市場可分為兒童（17歲以下）、成人（18-64歲）及老年人（65歲以上）。依地區分類，市場可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球植入式胰島素幫浦市場促進因素

全球植入式胰島素幫浦市場的主要促進因素之一是糖尿病（尤其是第1型糖尿病）在全球範圍內的日益普及。這種激增主要歸因於肥胖率上升、久坐的生活方式以及遺傳因素。隨著糖尿病管理變得愈發重要，人們對能夠提供更佳血糖控制和更靈活治療方案的先進技術的需求也日益成長，從而改善患者的生活品質。植入式胰島素幫浦因其能夠持續輸注胰島素、減少頻繁注射的需求以及實現個人化治療，而備受尋求有效糖尿病管理方案的患者和醫療保健提供者的青睞。

限制全球植入式胰島素幫浦市場的因素

全球植入式胰島素幫浦市場面臨的主要限制因素之一是設備及其維護的高成本。初始投資和持續費用，包括植入手術、維護和定期更換，對許多患者和醫療機構都難以負擔。此外，該技術的複雜性以及患者和醫療專業人員都需要接受專門培訓，進一步阻礙了其推廣應用。這些經濟和後勤方面的挑戰可能會疏遠潛在用戶，並限制市場擴張，尤其是在醫療資金和基礎設施薄弱的地區。

全球植入式胰島素幫浦市場趨勢

全球植入式胰島素幫浦市場正經歷一個重大趨勢：這些設備與持續血糖監測（CGM）系統的融合。這種融合催生了先進的閉合迴路系統，通常被稱為人工胰臟解決方案，它能夠根據即時血糖測量值自動調節胰島素劑量。隨著此類智慧整合技術的日益普及，它們將提高治療的精準度，簡化日常糖尿病管理，並增強患者對自身健康的信心。這一趨勢凸顯了醫療保健解決方案向個人化和自動化方向發展的趨勢，從而提高糖尿病管理的效率，並改善患者的整體治療效果。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 重大投資機會
  • 市場生態系統
  • 市場吸引力指數（2024）
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球植入式胰島素幫浦市場規模（按幫浦類型和複合年成長率分類）（2025-2032 年）

  • 市場概覽
  • 可程式設計植入式泵
  • 閉合迴路泵
  • 開放回路泵
  • 不可編程植入式泵
  • 其他

全球植入式胰島素幫浦市場規模（按儲液器容量和複合年成長率分類）（2025-2032 年）

  • 市場概覽
  • 小體積（10毫升或更少）
  • 中等容量（10-20毫升）
  • 大容量（>20毫升）
  • 其他

全球植入式胰島素幫浦市場規模（按輸送方式及複合年成長率分類）（2025-2032 年）

  • 市場概覽
  • 持續基礎給藥
  • 大劑量投藥
  • 基礎-餐時聯合治療
  • 其他

全球植入式胰島素幫浦市場規模（按最終用戶和複合年成長率分類）（2025-2032 年）

  • 市場概覽
  • 醫院
  • 門診手術中心（ASC）
  • 糖尿病診所
  • 居家照護
  • 其他

全球植入式胰島素幫浦市場規模（依年齡層分類）及複合年成長率（2025-2032 年）

  • 市場概覽
  • 兒童（17歲以上）
  • 成年人（18-64歲）
  • 老年人（65歲以上）

全球植入式胰島素幫浦市場規模（按適應症和複合年成長率分類）（2025-2032 年）

  • 市場概覽
  • 1型糖尿病（T1DM）
  • 2型糖尿病（T2DM）
  • 其他

全球植入式胰島素幫浦市場規模（按分銷管道和複合年成長率分類）（2025-2032 年）

  • 市場概覽
  • 兒童（17歲以上）
  • 成年人（18-64歲）
  • 老年人（65歲以上）

全球植入式胰島素幫浦市場規模及複合年成長率（2025-2032）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位（2024 年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析（2024 年）
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2022-2024年營收年比比較

主要企業簡介

  • Medtronic Plc.（Ireland）
  • Insulet Corporation（United States）
  • Tandem Diabetes Care, Inc.（United States）
  • F. Hoffmann-La Roche AG（Switzerland）
  • Ypsomed AG（Switzerland）
  • SOOIL Development Co., Ltd.（South Korea）
  • Novo Nordisk（Denmark）
  • Johnson & Johnson（United States）
  • Bigfoot Biomedical, Inc.（United States）
  • Beta Bionics（United States）
  • Diabeloop SACA（France）
  • Debiotech SA（Switzerland）
  • Terumo Corporation（Japan）
  • Wuxi Apex Medical Co., Ltd.（China）
  • ViCentra BV（Netherlands）
  • CeQur（Switzerland）
  • Medtrum Technologies Inc.（China）
  • MicroPort Scientific（China）
  • Menarini Diagnostics Srl（Italy）
  • Ascensia Diabetes Care（Switzerland）

結論與建議

簡介目錄
Product Code: SQMIG35A3126

Global Implantable Insulin Pump Market size was valued at USD 32.2 billion in 2023 and is poised to grow from USD 39.35 billion in 2024 to USD 195.66 billion by 2032, growing at a CAGR of 22.2% during the forecast period (2025-2032).

The global implantable insulin pump market is experiencing robust growth, driven by the escalating prevalence of diabetes, which fuels demand for advanced insulin delivery systems. Patients increasingly favor continuous and precise insulin management, stemming from a desire for better diabetes control to mitigate long-term complications. Technological advancements have led to enhancements in pump design, improving reliability and user-friendliness. Rising awareness of effective diabetes management, coupled with supportive healthcare policies and reimbursement programs, further promotes adoption. However, challenges such as high costs, surgical expenses, limited awareness in developing regions, stringent regulatory hurdles, potential infection risks, and the necessity for ongoing device maintenance may hinder market expansion. Overall, the landscape presents both opportunities and obstacles for implantable insulin pump growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Implantable Insulin Pump market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Implantable Insulin Pump Market Segments Analysis

Global Implantable Insulin Pump Market is segmented by Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel and region. Based on Pump Type, the market is segmented into Programmable Implantable Pumps, Closed-loop Pumps, Open-loop Pumps, Non-programmable Implantable Pumps and Others. Based on Reservoir Size, the market is segmented into Small Volume (<=10 mL), Medium Volume (10-20 mL), Large Volume (>20 mL) and Others. Based on Delivery Mode, the market is segmented into Continuous Basal Delivery, Bolus Delivery, Combined Basal-Bolus Delivery and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Diabetes Clinics, Homecare Settings and Others. Based on Age Group, the market is segmented into Pediatric (<=17 years), Adults (18-64 years) and Geriatric (>=65 years). Based on Indication, the market is segmented into Type 1 Diabetes Mellitus (T1DM), Type 2 Diabetes Mellitus (T2DM) and Others. Based on Distribution Channel, the market is segmented into Pediatric (<=17 years), Adults (18-64 years) and Geriatric (>=65 years). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Implantable Insulin Pump Market

One of the key market drivers for the global implantable insulin pump market is the increasing prevalence of diabetes, particularly type 1 diabetes, across the globe. This surge is largely attributed to rising obesity rates, sedentary lifestyles, and genetic factors. As diabetes management becomes more critical, there is a growing demand for advanced technologies that provide better glycemic control, flexibility, and improved quality of life for patients. Implantable insulin pumps offer continuous insulin delivery, reducing the need for frequent needle injections and allowing for personalized therapy, thus appealing to both patients and healthcare providers in their quest for effective diabetes management solutions.

Restraints in the Global Implantable Insulin Pump Market

One significant market restraint for the global implantable insulin pump market is the high cost associated with the devices and their management. The initial investment and ongoing expenses, including surgeries for implantation, maintenance, and the need for regular replacements, can be prohibitive for many patients and healthcare providers. Additionally, the complexity of the technology and the necessity for specialized training for both patients and healthcare professionals further complicate adoption. These financial and logistical challenges may deter potential users and limit market expansion, particularly in regions with less robust healthcare funding and infrastructure.

Market Trends of the Global Implantable Insulin Pump Market

The Global Implantable Insulin Pump market is witnessing a significant trend towards the integration of these devices with Continuous Glucose Monitoring (CGM) systems. This fusion leads to the emergence of advanced closed-loop systems, often described as artificial pancreas solutions, which facilitate automatic insulin delivery adjustments based on real-time glucose readings. As these smart integrations gain traction, they enhance treatment precision, streamline daily diabetes management, and bolster patient assurance in their health regimes. This trend underscores a broader movement towards personalized and automated healthcare solutions, making diabetes management more efficient and improving overall patient outcomes in the process.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Implantable Insulin Pump Market Size by Pump Type & CAGR (2025-2032)

  • Market Overview
  • Programmable Implantable Pumps
  • Closed-loop Pumps
  • Open-loop Pumps
  • Non-programmable Implantable Pumps
  • Others

Global Implantable Insulin Pump Market Size by Reservoir Size & CAGR (2025-2032)

  • Market Overview
  • Small Volume (<=10 mL)
  • Medium Volume (10-20 mL)
  • Large Volume (>20 mL)
  • Others

Global Implantable Insulin Pump Market Size by Delivery Mode & CAGR (2025-2032)

  • Market Overview
  • Continuous Basal Delivery
  • Bolus Delivery
  • Combined Basal-Bolus Delivery
  • Others

Global Implantable Insulin Pump Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Diabetes Clinics
  • Homecare Settings
  • Others

Global Implantable Insulin Pump Market Size by Age Group & CAGR (2025-2032)

  • Market Overview
  • Pediatric (<=17 years)
  • Adults (18-64 years)
  • Geriatric (>=65 years)

Global Implantable Insulin Pump Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Type 1 Diabetes Mellitus (T1DM)
  • Type 2 Diabetes Mellitus (T2DM)
  • Others

Global Implantable Insulin Pump Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Pediatric (<=17 years)
  • Adults (18-64 years)
  • Geriatric (>=65 years)

Global Implantable Insulin Pump Market Size & CAGR (2025-2032)

  • North America (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
    • US
    • Canada
  • Europe (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Pump Type, Reservoir Size, Delivery Mode, End User, Age Group, Indication, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Medtronic Plc. (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Insulet Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tandem Diabetes Care, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ypsomed AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SOOIL Development Co., Ltd. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novo Nordisk (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bigfoot Biomedical, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beta Bionics (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diabeloop SACA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Debiotech S.A. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wuxi Apex Medical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ViCentra B.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CeQur (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtrum Technologies Inc. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Menarini Diagnostics S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ascensia Diabetes Care (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations